Vascular Endothelial Growth Factor Gene Polymorphisms May Predict the Risk of Acute Graft-versus-Host Disease following Allogeneic Transplantation: Preventive Effect of Vascular Endothelial Growth Factor Gene on Acute Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 12, 2008, Pages 1408-1416

  Kim, Dong Hwan ^a,b   Lee, Nan Young ^a   Lee, Myung Hoon ^a   Sohn, Sang Kyun ^a  

^a Kyungpook National University Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Allogeneic stem cell transplantation; Graft versus host disease; Single nucleotide polymorphism; Vascular endothelial growth factor

Indexed keywords

ADENOSINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTIDINE; FLUDARABINE; GUANOSINE; METHOTREXATE; TACROLIMUS; THYMIDINE; THYMOCYTE ANTIBODY; VASCULOTROPIN A;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GRAFT RECIPIENT; HAPLOTYPE; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PREDICTION; PRIMARY PREVENTION; PROTECTION; PROTEIN SYNTHESIS; REDUCED INTENSITY CONDITIONING; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HUMANS; INCIDENCE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 56549097409     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.09.022     Document Type: Article

References (34)

1. Biedermann B.C., Sahner S., Gregor M., et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 359 (2002) 2078-2083
2. Thomas K.A. Vascular endothelial growth factor, a potent and selective angiogenic agent. The Journal of biological chemistry 271 (1996) 603-606
3. Klagsbrun M., and D'Amore P.A. Vascular endothelial growth factor and its receptors. Cytokine & growth factor reviews 7 (1996) 259-270
4. Min C.K., Kim S.Y., Lee M.J., et al. Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation. Bone marrow transplantation 38 (2006) 149-156
5. Wen F.Q., Liu X., Manda W., et al. TH2 Cytokine-enhanced and TGF-beta-enhanced vascular endothelial growth factor production by cultured human airway smooth muscle cells is attenuated by IFN-gamma and corticosteroids. The Journal of allergy and clinical immunology 111 (2003) 1307-1318
6. Nachbaur D., Schumacher P., Auberger J., Clausen J., and Kircher B. Vascular endothelial growth factor and activin-a serum levels following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13 (2007) 942-947
7. Tischer E., Mitchell R., Hartman T., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. The Journal of biological chemistry 266 (1991) 11947-11954
8. Vincenti V., Cassano C., Rocchi M., and Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93 (1996) 1493-1495
9. Brogan I.J., Khan N., Isaac K., Hutchinson J.A., Pravica V., and Hutchinson I.V. Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Human immunology 60 (1999) 1245-1249
10. Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., and Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. Journal of vascular research 37 (2000) 443-448
11. Watson C.J., Webb N.J., Bottomley M.J., and Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12 (2000) 1232-1235
12. Stevens A., Soden J., Brenchley P.E., Ralph S., and Ray D.W. Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer research 63 (2003) 812-816
13. Koukourakis M.I., Papazoglou D., Giatromanolaki A., Bougioukas G., Maltezos E., and Sivridis E. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 46 (2004) 293-298
14. Prior S.J., Hagberg J.M., Paton C.M., et al. DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption. American journal of physiology 290 (2006) H1848-H1855
15. Kim D.H., Lee N.Y., Sohn S.K., et al. IL-10 promoter gene polymorphism associated with the occurrence of chronic GVHD and its clinical course during systemic immunosuppressive treatment for chronic GVHD after allogeneic peripheral blood stem cell transplantation. Transplantation 79 (2005) 1615-1622
16. Kim D.H., Sohn S.K., Baek J.H., et al. Time to first flare-up episode of GVHD can stratify patients according to their prognosis during clinical course of progressive- or quiescent-type chronic GVHD. Bone marrow transplantation 40 (2007) 779-784
17. Lee S.J., Lee S.Y., Jeon H.S., et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 571-575
18. Nam E.J., Han S.W., Kim S.U., et al. Association of vascular endothelial growth factor gene polymorphisms with behcet disease in a Korean population. Hum Immunol 66 (2005) 1068-1073
19. Han S.W., Kim G.W., Seo J.S., et al. VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology (Oxford) 43 (2004) 1173-1177
20. Kim D.H., Lee N.Y., Lee M.H., Sohn S.K., Do Y.R., and Park J.Y. Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients. British journal of haematology 140 (2008) 71-79
21. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. American journal of human genetics 68 (2001) 978-989
22. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone marrow transplantation 15 (1995) 825-828
23. Shulman H.M., Sale G.E., Lerner K.G., et al. Chronic cutaneous graft-versus-host disease in man. The American journal of pathology 91 (1978) 545-570
24. Scrucca L., Santucci A., and Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone marrow transplantation 40 (2007) 381-387
25. Angelo L.S., and Kurzrock R. Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res 13 (2007) 2825-2830
26. Dvorak H.F., Detmar M., Claffey K.P., Nagy J.A., van de Water L., and Senger D.R. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. International archives of allergy and immunology 107 (1995) 233-235
27. Reinders M.E., Sho M., Izawa A., et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 112 (2003) 1655-1665
28. Kanazawa S., Tsunoda T., Onuma E., Majima T., Kagiyama M., and Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. The American journal of gastroenterology 96 (2001) 822-828
29. Kapsoritakis A., Sfiridaki A., Maltezos E., et al. Vascular endothelial growth factor in inflammatory bowel disease. International journal of colorectal disease 18 (2003) 418-422
30. Danese S., Sans M., de la Motte C., et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130 (2006) 2060-2073
31. Dickinson A.M., Middleton P.G., Rocha V., Gluckman E., and Holler E. Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol 127 (2004) 479-490
32. Kallianpur A.R. Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?. Bone Marrow Transplant 35 (2005) 1-16
33. Dickinson A.M., and Middleton P.G. Beyond the HLA typing age: genetic polymorphisms predicting transplant outcome. Blood Rev 19 (2005) 333-340
34. Krippl P., Langsenlehner U., Renner W., et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer 106 (2003) 468-471